联环药业：拟1500万元与南京大学合作开展抗血栓小核酸药物联合研发

Core Viewpoint - The company plans to collaborate with Nanjing University for the joint development of "anti-thrombotic small nucleic acid drugs," with a transaction amount of 15 million yuan [1] Group 1 - The collaboration aims to leverage academic research for drug development [1] - The transaction amount indicates a significant investment in innovative pharmaceutical research [1]